Tekla Capital Management’s St Jude Medical STJ Stock Holding History

Tekla Capital Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-158,805	Closed	-$12.4M	–	160
2016 Q2	$12.4M	Sell	158,805 -97,005	-38%	-$6.92M	0.51%	48
2016 Q1	$14.1M	Hold	255,810	–	–	0.6%	38
2015 Q4	$15.8M	Buy	255,810 +94,300	+58%	+$5.95M	0.57%	36
2015 Q3	$10.2M	Hold	161,510	–	–	0.37%	58
2015 Q2	$11.8M	Hold	161,510	–	–	0.43%	52
2015 Q1	$10.6M	Buy	161,510 +39,000	+32%	+$2.59M	0.42%	61
2014 Q4	$7.97M	Hold	122,510	–	–	0.37%	60
2014 Q3	$7.37M	Buy	+122,510	New	+$8M	0.35%	62

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Tekla Capital Management's STJ Position: Q3 2016 in Review

Tekla Capital Management sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 158,805 shares — an estimated $12.4M sold.

Tekla Capital Management first reported a position in STJ in Q3 2014 and held it in 8 quarters. The position peaked at $15.8M in Q4 2015. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

Tekla Capital Management reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
Tekla Capital Management sold 158,805 St Jude Medical shares in Q3 2016, an estimated $12.4M.
Tekla Capital Management first reported a position in St Jude Medical in Q3 2014 and held it in 8 quarters.
Tekla Capital Management's St Jude Medical position peaked at $15.8M in Q4 2015.
570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Tekla Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.